Concepedia

Efficacy and Safety of Intranasal Peptide YY3–36 for Weight Reduction in Obese Adults

Ira Gantz, Ngozi Erondu, Madhuja Mallick, Bret J. Musser, Rajesh Krishna, Wesley Tanaka, Karen Snyder, Cathy Stevens, Mark Stroh, Haiyuan Zhu,

The Journal of Clinical Endocrinology & Metabolism · 2007 · 160 citations · 34 references

DOIFull text

Open access

Abstract

Intranasal PYY(3-36) as administered at these intervention doses and preprandial timing is not efficacious in inducing weight loss in obese patients after 12 wk of treatment.

References

34

Gut hormone PYY3-36 physiologically inhibits food intake

Rachel L. Batterham, Michael A. Cowley, Caroline J. Small et al. · Nature · 2002 · 2.3K citations

, , +10

Inhibition of Food Intake in Obese Subjects by Peptide YY<sub>3–36</sub>

Rachel L. Batterham, Mark A. Cohen, Carel W. le Roux et al. · New England Journal of Medicine · 2003 · 1.6K citations

Sniffing neuropeptides: a transnasal approach to the human brain

Jan Born, Tanja Lange, Werner Kern et al. · Nature Neuroscience · 2002 · 1.3K citations

, , +8

Human distribution and release of a putative new gut hormone, peptide YY

Thomas E. Adrian, Gian‐Luca Ferri, A.J. Bacarese-Hamilton et al. · Gastroenterology · 1985 · 1.1K citations · Full text

, , +9

Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters

Carel W. le Roux, Simon Aylwin, Rachel L. Batterham et al. · Annals of Surgery · 2005 · 978 citations · Full text